Refreshed just now
https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/regulations-guidance-policy-documents
Why it’s here: This CMS page covers the Medicare Drug Price Negotiation Program final rule, guidance, and information collections, which is federal drug-pricing policy directly affecting biotechnology innovation (biosimilar delays, small biotech exceptions), so it is policy-relevant to the biotechnology area.
Trace across the boardItem
11d agoCenters for Medicare & Medicaid Services (CMS)https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/regulations-guidance-policy-documentsCMS posted its Medicare Drug Price Negotiation Program regulations hub after issuing the CMS-4215-F final rule on November 5, 2026, along with IPAY 2029 timelines and upcoming manufacturer submission deadlines.1 outlet7 linked
Connected
6 links- Newshttps://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-inflation-rebate-programBoth involve Inflation Reduction Act, Centers for Medicare & Medicaid Services
- Newshttps://www.cms.gov/initiatives/health-technology-ecosystem/overview/clinical-si-roadmapBoth involve Centers for Medicare & Medicaid Services
- NewsCMS postpones RPM payment halt for 2 yearsBoth involve Centers for Medicare & Medicaid Services
- NewsMedicare’s AI-assisted coverage review pilot hit early snags, documents showBoth involve Centers for Medicare & Medicaid Services
- MoneyEPATHUSA, INC. — Centers for Medicare and Medicaid Services award 75FCMC26C0007Both involve Centers for Medicare & Medicaid Services
- NewsTrump administration releases roadmap to boost clinical AIBoth involve Centers for Medicare & Medicaid Services
About
- Inflation Reduction Act
- Office of Management and Budget
- Centers for Medicare & Medicaid Services
- Inflation Reduction Act drug price negotiation